Clinical characteristics of children with 2009 pandemic H1N1 influenza virus infections

Pediatrics International

Volumn 53, Issue 4, 2011, Pages 426-430

  Dubnov Raz, Gal ^a,b   Somech, Raz ^a,b   Warschawski, Yaniv ^a,b,c   Eisenberg, Gilad ^a,b,c   Bujanover, Yoram ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

hospitalization; influenza; pandemic; pediatrics

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; OSELTAMIVIR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HOSPITALIZATION; CLINICAL FEATURE; COUGHING; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; FLU LIKE SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; INFANT; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; ISRAEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPEATED DRUG DOSE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS DETECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; ISRAEL; MALE; PANDEMICS;

EID: 80051978348     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03271.x     Document Type: Article

References (19)

1. Fraser C, Donnelly CA, Cauchemez S, et al,. for the WHO Rapid Pandemic Assessment Collaboration. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 2009; 324: 1557-61.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, et al,. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009; 360: 2605-15.
3. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al,. INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 2009; 361: 680-9.
4. Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection-United States, April-August 2009. MMWR Morb. Mortal. Wkly Rep. 2009; 58: 941-7.
5. Jain S, Kamimoto L, Bramley AM, et al,. for the 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N. Engl. J. Med. 2009; 361: 1935-44.
6. Thompson WW, Shay DK, Weintraub E, et al,. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-40. (Pubitemid 39223224)
7. Peiris JS, Poon LL, Guan Y,. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J. Clin. Virol. 2009; 45: 169-73.
8. Jain R, Goldman RD,. Novel influenza A(H1N1): Clinical presentation, diagnosis, and management. Pediatr. Emerg. Care. 2009; 25: 791-6.
9. Libster R, Bugna J, Coviello S, et al,. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N. Engl. J. Med. 2010; 362: 45-55.
10. Miroballi Y, Baird JS, Zackai S, et al,. Novel influenza A(H1N1) in a pediatric health care facility in New York City during the first wave of the 2009 pandemic. Arch. Pediatr. Adolesc. Med. 2010; 164: 24-30.
11. Lister P, Reynolds F, Parslow R, et al,. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 2009; 374: 605-7.
12. Cao B, Li XW, Mao Y, et al,. National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N. Engl. J. Med. 2009; 361: 2507-17.
13. Hackett S, Hill L, Patel J, et al,. Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet 2009; 374: 605.
14. Bettinger JA, Sauvé LJ, Scheifele DW, et al,. Pandemic influenza in Canadian children: A summary of hospitalized pediatric cases. Vaccine 2010; 28: 3180-4.
15. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D,. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010; 182: 39-44.
16. Koliou M, Soteriades ES, Toumasi MM, Demosthenous A, Hadjidemetriou A,. Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: The first 45 cases in Cyprus, June-August 2009. Euro Surveill. 2009; 14 (33): pii 19312.
17. Koliou M, Hadjiloizou S, Ourani S, Demosthenous A, Hadjidemetriou A,. A case of Benign Acute Childhood Myositis associated with Influenza A (H1N1) virus infection. Clin. Microbiol. Infect. 2010; 16: 193-5.
18. Hasegawa M, Hashimoto K, Morozumi M, Ubukata K, Takahashi T, Inamo Y,. Spontaneous pneumomediastinum complicating pneumonia in children infected with 2009 pandemic influenza A(H1N1) virus. Clin. Microbiol. Infect. 2010; 16: 195-9.
19. Hong DK, Tremoulet AH, Burns JC, Lewis DB,. Cross-reactive neutralizing antibody against pandemic 2009 h1n1 influenza a virus in intravenous immunoglobulin preparations. Pediatr. Infect. Dis. J. 2010; [Epub ahead of print].